Ravelcare IPO Subscribed 438x, GMP 62% – Listing Update
Ravelcare, the digital beauty disruptor specializing in customized hair and skincare, closed its IPO on a high note with 438x overall subscription (retail at 463x!). As of Dec 5, 2025, Ravelcare IPO GMP holds at ₹80, pointing to a ₹210 estimated listing – 62% premium over ₹130 band. Allotment out today, listing Dec 8 on BSE SME.
What Fueled the Subscription Fire?
- Retail rush: 463x bid, thanks to Gen Z’s love for personalized BPC products.
- GMP surge: From ₹16 (Nov 26) to ₹80 – reflects post-close optimism.
- Fundraise: Full fresh issue of ₹24.10 Cr for scaling e-com and outlets.
- Market fit: 27% EBITDA margins in competitive beauty space.
Key Metrics Table
| Issue Price (Upper Band) | ₹130 |
|---|---|
| Current GMP | ₹80 |
| Estimated Listing Price | ₹210 |
| Potential Gain | 62% |
Investment Play?
Strong buy for beauty sector bulls (India’s $20B market by 2025). Risks: Competition from Nykaa. Aim for 50%+ listing flip.
Verdict: A subscriber’s dream – Dec 8 could sparkle!
Ravelcare IPO GMP, Ravelcare IPO subscription 438x, Ravelcare beauty IPO review, Ravelcare listing Dec 8, Ravelcare IPO expected gain